1. Shimagami H, Yamaguchi Y, Kato Y, Kumanogoh A. Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy. BMJ Case Rep. 2022 Mar 2;15(3):e246533. doi: 10.1136/bcr-2021-246533.
2. Enomoto T, Shiroyama T, Hirata H, Amiya S, Adachi Y, Niitsu T, Noda Y, Hara R, Fukushima K, Suga Y, Miyake K, Koyama S, Iwahori K, Nagatomo I, Tokuhira N, Uchiyama A, Takeda Y, Kumanogoh A. COVID-19 in a human T-cell lymphotropic virus type-1 carrier. Clin Case Rep. 2022 Feb 15;10(2):e05463. doi: 10.1002/ccr3.5463. eCollection 2022 Feb.
3. Amiya S, Fujimoto J, Matsumoto K, Yamamoto M, Yamamoto Y, Yoneda M, Kuge T, Miyake K, Shiroyama T, Hirata H, Takeda Y, Kumanogoh A. Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination. Int J Infect Dis. 2022 Mar;116:255-257. doi: 10.1016/j.ijid.2022.01.031. Epub 2022 Jan 19.
4. Funakoshi K, Morita T, Kumanogoh A. Longer Prehospitalization and Preintubation Periods in Intubated Non-survivors and ECMO Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2021 Oct 15;8:727101. doi: 10.3389/fmed.2021.727101. eCollection 2021.
5. Yamamoto Y, Shiroyama T, Hirata H, Kuge T, Matsumoto K, Yoneda M, Yamamoto M, Uchiyama A, Takeda Y, Kumanogoh A.Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19J Med Virol. 2021 Oct 28:10.1002/jmv.27421. doi: 10.1002/jmv.27421. Online ahead of print.
6. Okamoto M, Kawada S, Shimagami H, Fujii N, Matsukawa K, Ishikawa N, Kawamoto K, Higa S, Ishida Y, Ogata A, Yamaguchi Y, Morita T, Kato Y, Kumanogoh A.Rapid attenuation of anti-SARS-CoV-2 antibodies in patients with musculoskeletal diseases in whom intensive immunosuppressive therapies were reinitiated after COVID-19: comment on the article by Curtis et alArthritis Rheumatol. 2022 Apr;74(4):726-728. doi: 10.1002/art.42003. Epub 2022 Feb 25.
7. Lu X, Hosono Y, Nagae M, Ishizuka S, Ishikawa E, Motooka D, Ozaki Y, Sax N, Maeda Y, Kato Y, Morita T, Shinnakasu R, Inoue T, Onodera T, Matsumura T, Shinkai M, Sato T, Nakamura S, Mori S, Kanda T, Nakayama EE, Shioda T, Kurosaki T, Takeda K, Kumanogoh A, Arase H, Nakagami H, Yamashita K, Takahashi Y, Yamasaki S.Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patientsJ Exp Med. 2021 Dec 6;218(12):e20211327. doi: 10.1084/jem.20211327. Epub 2021 Oct 14.
8. Noda Y, Shiroyama T, Amiya S, Adachi Y, Enomoto T, Hara R, Niitsu T, Miyake K, Hirata H, Takeda Y, Kumanogoh A.COVID-19 in a patient with sporadic lymphangioleiomyomatosis awaiting lung transplantationRespir Med Case Rep. 2021;34:101505. doi: 10.1016/j.rmcr.2021.101505. Epub 2021 Sep 3.
9. Niitsu T, Shiroyama T, Hirata H, Noda Y, Adachi Y, Enomoto T, Hara R, Amiya S, Uchiyama A, Takeda Y, Kumanogoh A.Cytomegalovirus infection in critically ill patients with COVID-19J Infect. 2021 Oct;83(4):496-522. doi: 10.1016/j.jinf.2021.07.004. Epub 2021 Jul 9.
10. COVID-19 Host Genetics Initiative.Mapping the human genetic architecture of COVID-19Nature. 2021 Dec;600(7889):472-477. doi: 10.1038/s41586-021-03767-x. Epub 2021 Jul 8.